Follow-On Biologics: Is Your Patent Portfolio Ready?
Far less publicized is the fact that a subtitle of H.R. 3590, the “Biologics Price Competition and Innovation Act of 2009,” creates the legal and regulatory framework for the approval of follow-on biologics (“FOBs”).
Some highlights of the legislation include: 1) creation of a patent information exchange regime prior to FOB patent litigation;...
To view the full article, register now.